Investing.com -- Raymond James downgraded Danaher Corporation (NYSE:DHR) to "Market Perform" from "Outperform," citing concerns over the company's growth trajectory following its fourth-quarter results and guidance that lagged peers.
The brokerage noted that Danaher's high-value portfolio, previously expected to generate leading growth, now appears less compelling as its organic growth forecast of about 3% offers limited upside compared to rivals. Analysts also flagged a lack of confidence in the company's long-term earnings growth outlook, calling management’s tone on key metrics "unsettling."
Raymond (NSE:RYMD) James said it expects the stock’s valuation premium over competitors like Thermo Fisher (NYSE:TMO) to compress, as Danaher is "not poised for major outperformance" and may struggle to justify its historical premium.
Meanwhile, the brokerage reiterated an "Outperform" rating on Thermo Fisher, highlighting its clearer growth outlook and relative valuation discount.
Related Articles
Raymond James downgrades Danaher on murky growth outlook
Canada Goose stock falls on new US tariffs
Factbox-From Johnnie Walker to Corona beer, major alcohol firms could see tariff hit
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。